GlassScriptPhysician profile
Abhiram Duvvuri
NPI 1124383039
$5,368.18
in general payments reported to CMS, 2019-2025
18 companies · $848 in 2025
The $848 reported for 2025 was more than what 94% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2020: $1,667 · 2021: $1,831 · 2022: $20.54 · 2023: $92.19 · 2024: $785 · 2025: $848.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,337 · Travel and Lodging: $358 · Education: $30.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,336.55 |
| Travel and Lodging | $358.08 |
| Education | $30.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $3,362.75 | 2019-2021 | |
| Boston Scientific Corporation | $760.75 | 2024-2025 | General - Polypectomy |
| Abbvie INC. | $381.84 | 2019-2025 | Rinvoq, Skyrizi |
| Janssen Biotech, INC. | $155.16 | 2025 | Tremfya |
| Pfizer INC. | $150.29 | 2024-2025 | |
| Medtronic, INC. | $149.70 | 2021 | |
| Genzyme Corporation | $121.36 | 2025 | |
| Merit Medical Systems INC | $69.69 | 2025 | Esophyx |
| Abbott Laboratories | $48.06 | 2023 | Cardiomems |
| Ferring Pharmaceuticals INC. | $27.36 | 2023 | Rebyota |
| Ardelyx, INC. | $22.05 | 2025 | Ibsrela |
| Intercept Pharmaceuticals, INC. | $21.34 | 2024 | |
| Celltrion USA INC. | $18.50 | 2024 | Vegzelma |
| Regeneron Healthcare Solutions, INC. | $17.94 | 2025 | Dupixent |
| Takeda Pharmaceuticals U.S.A., INC. | $16.69 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biocon Biologics INC | $16.02 | 2025 | Yesintek |
| Janssen Pharmaceuticals, INC | $14.54 | 2021 | |
| Ironwood Pharmaceuticals, INC | $14.14 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abhiram Duvvuri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.